Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cedergrenska | 41C | Nov 22, 2024 | 2.28 | +3.64 |
Cegedim | C7E | Nov 22, 2024 | 10.75 | -2.27 |
Cel-Sci Corp. | LSRM | Nov 22, 2024 | 0.56 | -1.75 |
Celanese Corp | DG3 | Nov 22, 2024 | 72.16 | +4.82 |
Celestica, Inc. | CTW0 | Nov 22, 2024 | 85.50 | -1.72 |
CELL IMPACT AB | ICLA | Nov 22, 2024 | 0.02 | +45.19 |
CellaVision | C26 | Nov 22, 2024 | 18.28 | +1.67 |
Cellcom Israel Limited | F5U | Nov 22, 2024 | 4.72 | +3.51 |
Celldex Therapeutics, Inc. | TCE2 | Nov 22, 2024 | 24.80 | 0.00 |
Cellectar Biosciences | NV4 | Nov 22, 2024 | 1.47 | +6.52 |
Cellectis | ZVA | Nov 22, 2024 | 1.73 | +0.70 |
Cellectis S.A. - American Depositary Shares | ZVAA | Nov 22, 2024 | 1.72 | +0.58 |
CELLINK B | 49Z | Nov 22, 2024 | 3.07 | -1.66 |
Cellnex Telecom S.A. | 472 | Nov 22, 2024 | 32.41 | +2.56 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Nov 22, 2024 | 15.30 | +2.00 |
Cellular Goods Plc | 6XS | Nov 22, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Nov 22, 2024 | 5.70 | -5.47 |
Celsion Corporation | CBO | Nov 22, 2024 | 0.66 | +13.79 |
Celsius Resources Limited | FX8 | Nov 22, 2024 | 0.01 | -31.25 |
Celtic plc | CCP | Nov 22, 2024 | 1.88 | 0.00 |
Celyad Oncology | 1C0 | Nov 22, 2024 | 0.61 | -5.57 |
Cemat | 1X9 | Nov 22, 2024 | 0.13 | +1.20 |
CEMBRE S.P.A. EO 0,52 | J0L | Nov 22, 2024 | 41.45 | +2.85 |
Cementir Holding N.V. | 3PC | Nov 22, 2024 | 11.30 | +4.63 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | Nov 22, 2024 | 5.60 | -0.89 |
Cemex S.A.B. De C.V. | CEXA | Nov 22, 2024 | 5.15 | +0.98 |
Cemex S.A.B. De C.V. CPO | CEXB | Nov 22, 2024 | 0.51 | 0.00 |
Cenergy Holdings | 9CN | Nov 22, 2024 | 7.82 | -1.01 |
Cenit AG | CSH | Nov 22, 2024 | 8.60 | -2.27 |
Cenovus Energy Inc | CXD | Nov 22, 2024 | 15.54 | -0.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.